Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 9,535 shares at $35.75 ($341K) on 2021-11-17, disclosed to the SEC on 2021-11-19.
Open-market sale of $341k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.75 | 4,535 | $162K | 47.5% |
| 2 | $35.75 | 4,535 | $162K | 47.5% |
| 3 | $36.80 | 465 | $17K | 5.0% |
| Total | $35.80 avg | 9,535 | $341K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |